TME PHARMA NV (ALTME.PA) Stock Cash Flow
Europe - Euronext Paris - EPA:ALTME - NL0015000YE1 - Common Stock
0.0637 EUR
+0 (+5.29%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -4.57M | -5.72M | -6.73M | -15.13M | -14.45M | |||
| Depreciation Amortization | 19.00K | 78.00K | 144.00K | 92.00K | 70.00K | |||
| Change In Working Capital | -359.00K | 217.00K | -561.00K | -720.00K | 410.00K | |||
| Interest Paid | 0.00 | 2.00K | 13.00K | 11.00K | 0.00 | |||
| Taxes Paid | -2.00K | 0.00 | 6.00K | 0.00 | N/A | |||
| Other non cash items | 156.00K | 793.00K | 1.52M | 3.61M | 1.60M | |||
| OPERATING CASH FLOW | -4.76M | -4.63M | -5.63M | -12.14M | -12.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -12.00K | -16.00K | -19.00K | -21.00K | -10.00K | |||
| Other Investing Activity | 7.00K | -5.00K | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | -5.00K | -21.00K | -19.00K | -21.00K | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.70M | -1.22M | -39.00K | 7.37M | 4.35M | |||
| Stock Issued/Repurchased | 2.56M | 6.08M | 3.17M | 56.00K | 7.22M | |||
| Other Financing Activity | -137.00K | 800.00K | 140.00K | -145.00K | -70.00K | |||
| FINANCING CASH FLOW | 4.13M | 5.66M | 3.27M | 7.29M | 11.50M | |||
| Exchange Rate Effect | -9.00K | -10.00K | -1.00K | 57.00K | 50.00K | |||
| CHANGE IN CASH | -644.00K | 995.00K | -2.39M | -4.82M | -840.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.76M | -4.63M | -5.63M | -12.14M | -12.38M | |||
| Capital Expenditure | -12.00K | -16.00K | -19.00K | -21.00K | -10.00K | |||
| FREE CASH FLOW | -4.77M | -4.65M | -5.65M | -12.16M | -12.39M | |||
All data in EUR